Semapimod
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Semapimod
- DrugBank Accession Number
- DB12094
- Background
Semapimod has been used in trials studying the treatment of Crohn Disease.
- Type
- Small Molecule
- Groups
- Investigational
- Structure
- Weight
- Average: 744.914
Monoisotopic: 744.452062986 - Chemical Formula
- C34H52N18O2
- Synonyms
- Semapimod
- External IDs
- CPSI-2364 FREE BASE
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Product Ingredients
Ingredient UNII CAS InChI Key Semapimod mesylate 8W415THB21 872830-80-3 CKWNYVLFZNKVGX-RTQZJKMDSA-N Semapimod tetrahydrochloride A16WYQ522A 164301-51-3 MAHASPGBAIQZLY-RTQZJKMDSA-N
Categories
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as anilides. These are organic heterocyclic compounds derived from oxoacids RkE(=O)l(OH)m (l not 0) by replacing an OH group by the NHPh group or derivative formed by ring substitution.
- Kingdom
- Organic compounds
- Super Class
- Benzenoids
- Class
- Benzene and substituted derivatives
- Sub Class
- Anilides
- Direct Parent
- Anilides
- Alternative Parents
- N-arylamides / Fatty amides / Secondary carboxylic acid amides / Guanidines / Organic oxides / Hydrocarbon derivatives / Carbonyl compounds
- Substituents
- Anilide / Aromatic homomonocyclic compound / Carbonyl group / Carboxamide group / Carboxylic acid derivative / Fatty acyl / Fatty amide / Guanidine / Hydrocarbon derivative / N-arylamide
- Molecular Framework
- Aromatic homomonocyclic compounds
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 9SGW2H1K8P
- CAS number
- 352513-83-8
- InChI Key
- PWDYHMBTPGXCSN-VCBMUGGBSA-N
- InChI
- InChI=1S/C34H52N18O2/c1-19(45-49-31(35)36)23-13-24(20(2)46-50-32(37)38)16-27(15-23)43-29(53)11-9-7-5-6-8-10-12-30(54)44-28-17-25(21(3)47-51-33(39)40)14-26(18-28)22(4)48-52-34(41)42/h13-18H,5-12H2,1-4H3,(H,43,53)(H,44,54)(H4,35,36,49)(H4,37,38,50)(H4,39,40,51)(H4,41,42,52)/b45-19+,46-20+,47-21+,48-22+
- IUPAC Name
- N,N'-bis({3,5-bis[(1E)-1-(carbamimidamidoimino)ethyl]phenyl})decanediamide
- SMILES
- C\C(=N/NC(N)=N)C1=CC(=CC(NC(=O)CCCCCCCCC(=O)NC2=CC(=CC(=C2)C(\C)=N\NC(N)=N)C(\C)=N\NC(N)=N)=C1)C(\C)=N\NC(N)=N
References
- General References
- Not Available
- External Links
- PubChem Compound
- 5745214
- PubChem Substance
- 347828398
- ChemSpider
- 4676528
- ChEMBL
- CHEMBL2107779
- ZINC
- ZINC000072266997
- Wikipedia
- Semapimod
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 2 Completed Treatment Crohn's Disease (CD) 3 2 Terminated Treatment Crohn's Disease (CD) 1 1 Completed Not Available Crohn's Disease (CD) 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.0377 mg/mL ALOGPS logP 1.47 ALOGPS logP 0.49 Chemaxon logS -4.3 ALOGPS pKa (Strongest Basic) 7.88 Chemaxon Physiological Charge 3 Chemaxon Hydrogen Acceptor Count 18 Chemaxon Hydrogen Donor Count 14 Chemaxon Polar Surface Area 355.24 Å2 Chemaxon Rotatable Bond Count 19 Chemaxon Refractivity 296.54 m3·mol-1 Chemaxon Polarizability 84.11 Å3 Chemaxon Number of Rings 2 Chemaxon Bioavailability 0 Chemaxon Rule of Five No Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 270.73682 predictedDeepCCS 1.0 (2019) [M+H]+ 272.79153 predictedDeepCCS 1.0 (2019) [M+Na]+ 278.6028 predictedDeepCCS 1.0 (2019)
Drug created at October 20, 2016 21:20 / Updated at February 21, 2021 18:53